References
- Carr N, Cecil TD, Mohamed F, et al. (2016). A consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: the results of the Peritoneal Surface Oncology Group International (PSOGI) modified Delphi process. Am J Surg Pathol 40:14–26.
- Smeenk RM, Verwaal VJ, Antonini N, Zoetmulder FA. (2007). Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg 245:104–9.
- Moran B, Cecil T, Chandrakumaran K, et al. (2015). The results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1200 patients with peritoneal malignancy. Colorectal Dis 17:772–8.
- Sugarbaker PH. (1995). Peritonectomy procedures. Ann Surg 221:29–42.
- Dayal S, Taflampas P, Riss S, et al. (2013). Complete cytoreduction for pseudomyxoma peritonei is optimal but maximal tumor debulking may be beneficial in patients in whom complete tumor removal cannot be achieved. Dis Colon Rectum 56:1366–72.
- Koh JL, Yan TD, Glenn D, Morris DL. (2009). Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis. Ann Surg Oncol 16:327–33.
- de Bree E, Koops W, Kroger R, et al. (2004). Peritoneal carcinomatosis from colorectal or appendiceal origin: correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement. J Surg Oncol 86:64–73.
- Jacquet P, Jelinek JS, Chang D, et al. (1995). Abdominal computed tomographic scan in the selection of patients with mucinous peritoneal carcinomatosis for cytoreductive surgery. J Am Coll Surg 181:530–8.
- Mirza A, Galloway S. (2016). Laparoscopy, computerised tomography and fluorodeoxyglucose positron emission tomography in the management of gastric and gastro-oesophageal junction cancers. Surg Endosc 30:2690–6.
- Iversen LH, Rasmussen PC, Laurberg S. (2013). Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis. Br J Surg 100:285–92.
- Chua TC, Yan TD, Saxena A, Morris DL. (2009). Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure? A systemic review of morbidity and mortality. Ann Surg 249:900–7.
- Coakley FV, Choi PH, Gougoutas CA, et al. (2002). Peritoneal metastases: detection with spiral CT in patients with ovarian cancer. Radiology 223:495–9.
- Low RN. (2016). Preoperative and surveillance MR imaging of patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy. J Gastrointest Oncol 7:58–71.
- Torkzad MR, Casta N, Bergman A, et al. (2015). Comparison between MRI and CT in prediction of peritoneal carcinomatosis index (PCI) in patients undergoing cytoreductive surgery in relation to the experience of the radiologist. J Surg Oncol 111:746–51.
- Low R, Barone RM, Gurney JM, Muller WD. (2008). Mucinous appendiceal neoplasms: preoperative MR staging and classification compared with surgical and histopathologic findings. Am J Roentgenol 190:656–65.
- Tabrizian P, Jayakrishnan TT, Zacharias A, et al. (2015). Incorporation of diagnostic laparoscopy in the management algorithm for patients with peritoneal metastases: a multi-institutional analysis. J Surg Oncol 111:1035–40.